EMA: Two-Stage design [Two-Stage / GS Designs]

posted by joyjac – Philippines, 2011-07-05 09:53 (5101 d 03:22 ago) – Posting: # 7207
Views: 5,037

Hi colleagues,

The EMEA guideline states that it is acceptable to use a two-stage approach when attempting to demonstrate bioequivalence. Can anyone enlighten me on this kind of study design, steps to be taken, stopping criteria or can we automatically switch to stage 2 if the BE fails at stage 1? Thanks and regards.


Edit: Category changed. [Helmut]

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,673 registered users;
57 visitors (0 registered, 57 guests [including 15 identified bots]).
Forum time: 13:15 CEST (Europe/Vienna)

Medical researches can be divided into two sorts:
those who think that meta is better and those
who believe that pooling is fooling.    Stephen Senn

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5